EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration

Junjie Cheng iD, Jinmeng Li iD, Ren Zheng iD, Kan Xu, Xiaoqing Ma, Junke Qiu, Ruoying Zhang iD, Xinjun Cai iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01437-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Junjie Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Cycloserine, Tuberculosis, Multidrug-Resistant, Antitubercular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Agriculture and Social Development Scientific Research Project, Hangzhou Biomedicine and Health Industry Development Project, Hangzhou Pharmaceutical Association Hospital Pharmaceutical Innovation Research Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cycloserine (Cs) is a crucial anti-multidrug-resistant tuberculosis medication with significant clinical efficacy. However, its clinical application is limited by neuropsychiatric-related adverse drug reactions (ADRs). This study retrospectively evaluated the peak plasma concentration ( C max ) of Cs and Cs-related neuropsychiatric ADRs and analyzed the risk factors of developing neuropsychiatric ADRs. A multivariable ordinal logistic regression model was built to predict the incidence of neuropsychiatric ADRs. This study enrolled a total of 136 participants, with a cumulative incidence of neuropsychiatric ADRs of 12.5%. Patients experiencing ADRs had significantly higher Cs C max compared to those without ADRs. The risk of ADRs rose with increasing Cs exposure, especially when C max exceeded 30 mg/L. Receiver operating characteristic analysis demonstrated the strong predictive value of C max for neuropsychiatric ADRs. Notably, the predictive efficacy of the logistic regression model significantly improved after incorporating drinking history as a covariate, achieving a final predictive accuracy of 87.6%. Cs C max serves as a critical indicator for predicting Cs-related neuropsychiatric ADRs. Dynamic monitoring of Cs C max combined with alcohol history assessment can enable accurate identification of high-risk populations for neuropsychiatric ADRs, thereby providing a scientific basis for developing individualized medication regimens and implementation of early interventions. IMPORTANCE Cycloserine (Cs) is a vital medication for treating multidrug-resistant tuberculosis (MDR-TB), but its use is often limited by severe neuropsychiatric side effects such as depression, anxiety, and seizures. This study highlights the critical role of monitoring Cs peak plasma concentration ( C max ) to predict and mitigate these adverse reactions. By analyzing data from 136 patients, the researchers found that higher Cs C max levels significantly increase the risk of neuropsychiatric toxicity, particularly when concentrations exceed 30 mg/L. Additionally, a history of alcohol consumption further elevates this risk. These findings provide a practical approach for clinicians: regular monitoring of Cs levels and assessing alcohol use can help identify high-risk patients early, enabling timely adjustments to treatment plans. This work not only enhances patient safety but also supports the broader goal of improving MDR-TB treatment outcomes by minimizing harmful side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CycloserineTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultRisk FactorsAgedYoung Adult

Stichwörter der Autor:innen

cycloserineneuropsychiatric-related adverse drug reactionspeak plasma concentration

Substanzen

CycloserineAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.
  • Department of Tuberculosis, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.

ORCID-Profile: Junjie Cheng, Jinmeng Li, Ren Zheng, Ruoying Zhang, Xinjun Cai

Förderung

  • Hangzhou Agriculture and Social Development Scientific Research Project
  • Hangzhou Biomedicine and Health Industry Development Project
  • Hangzhou Pharmaceutical Association Hospital Pharmaceutical Innovation Research Funding Project
  • Zhejiang Pharmaceutical Association Hospital Pharmacy Special Research Funding Project
  • Hangzhou Health Science and Technology Project
  • Zhejiang Natural Science Foundation Project

Zitieren

APA

Cheng, J., Li, J., Zheng, R., Xu, K., Ma, X., Qiu, J., Zhang, R., & Cai, X. (2025). Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01437-25

Vancouver

Cheng J, Li J, Zheng R, Xu K, Ma X, Qiu J, et al. Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01437-25

BibTeX
@article{Cheng2025,
  author = {Cheng, Junjie and Li, Jinmeng and Zheng, Ren and Xu, Kan and Ma, Xiaoqing and Qiu, Junke and Zhang, Ruoying and Cai, Xinjun},
  title = {Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01437-25}
}
Kostenlos starten →